SEC registrant · CIK 0001096294

GFR PHARMACEUTICALS INC

GFR PHARMACEUTICALS INC (CIK 0001096294, EIN 77-0517964) reported revenue of $4.27 million ($4,271,794) for FY2012 (2012-01-01 to 2012-12-31) and net income of $1.28 million ($1,277,175) for FY2012 (2012-01-01 to 2012-12-31), as filed in its 10-K filed 2013-03-29 (accession 0001437749-13-003698).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

Identifier	Value
CIK	0001096294
EIN	77-0517964
SIC industry code	2834 Pharmaceutical Preparations
State or country of incorporation	NV
Fiscal year end	December 31
Entity type	operating
Olympus entity ID	org_4414bnz0v5xynp13agf6yskpnx

The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

Metric	Value	Fiscal period	Period	Form	Filed	Accession number	XBRL concept
Revenue	$4,271,794	FY2012	2012-01-01 to 2012-12-31	10-K	2013-03-29	0001437749-13-003698	SalesRevenueNet
Net income	$1,277,175	FY2012	2012-01-01 to 2012-12-31	10-K	2013-03-29	0001437749-13-003698	NetIncomeLoss
Total assets	$12,166,364	FY2012	as of 2012-12-31	10-K	2013-03-29	0001437749-13-003698	Assets
Total liabilities	$1,589,081	FY2012	as of 2012-12-31	10-K	2013-03-29	0001437749-13-003698	Liabilities
Stockholders' equity	$9,829,881	FY2012	as of 2012-12-31	10-K	2013-03-29	0001437749-13-003698	StockholdersEquity
Operating cash flow	$1,198,438	FY2012	2012-01-01 to 2012-12-31	10-K	2013-03-29	0001437749-13-003698	NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share	$0.03 per share	FY2012	2012-01-01 to 2012-12-31	10-K	2013-03-29	0001437749-13-003698	EarningsPerShareBasicAndDiluted
Shares outstanding	42,079,940 shares	FY2012	as of 2013-03-25	10-K	2013-03-29	0001437749-13-003698	EntityCommonStockSharesOutstanding

Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2003-2012, newest first, each with its filing.

Metric	Fiscal period	Period	Value	Form	Filed	Accession number
Revenue	FY2012	2012-01-01 to 2012-12-31	$4,271,794	10-K	2013-03-29	0001437749-13-003698
Revenue	FY2011	2011-01-01 to 2011-12-31	$4,674,289	10-K	2013-03-29	0001437749-13-003698
Net income	FY2012	2012-01-01 to 2012-12-31	$1,277,175	10-K	2013-03-29	0001437749-13-003698
Net income	FY2011	2011-01-01 to 2011-12-31	$1,970,850	10-K	2013-03-29	0001437749-13-003698

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

Form	Filed	Period of report	Accession number	Document
10-Q	2013-05-14	2013-03-31	0001437749-13-005919	gfrp_10q-033113.htm
10-K	2013-03-29	2012-12-31	0001437749-13-003698	gfrp_10k-123112.htm
10-Q	2012-11-14	2012-09-30	0001437749-12-011642	gfr_10q-093012.htm
10-Q	2012-08-10	2012-06-30	0001437749-12-008173	gfr_10q-063012.htm
10-Q	2012-05-10	2012-03-31	0001437749-12-004796	gfr_10q-033112.htm
10-K	2012-03-23	2011-12-31	0001437749-12-002718	gfr_10k-123111.htm
10-Q	2011-11-08	2011-09-30	0001437749-11-008215	gfr_10q-093011.htm
10-Q	2011-08-12	2011-06-30	0001437749-11-005893	gfrpharm_10q-063011.htm
10-Q	2011-05-13	2011-03-31	0001144204-11-029089	v222522_10q.htm
10-K	2011-03-30	2010-12-31	0001144204-11-018185	v216525_10k.htm
10-Q	2010-11-12	2010-09-30	0001144204-10-059852	v202051_10q.htm
10-Q	2010-08-13	2010-06-30	0001144204-10-043359	v193545_10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

Scheme	Value	How linked	Source	Published
SEC Central Index Key (CIK) · OLY-US-SEC-CIK	0001096294	published by the source	data.sec.gov/submissions/CIK0001096294.json	2026-10-21
Employer Identification Number (EIN) · US-EIN	77-0517964	published by the source	data.sec.gov/submissions/CIK0001096294.json	2026-10-21

Former names

Name	From	To
LAREDO INVESTMENT CORP	1999-11-05	2004-08-09

Sources

EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001096294.json
EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001096294.json
Published by Olympus on Oct 21, 2026.
Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001096294" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001096294/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001096294/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"

MCP tool call

get_sec_company_financials {"cik":"1096294"}

On SEC EDGAR

Company filings on SEC EDGAR
Latest 10-K on SEC EDGAR — filed 2013-03-29, accession 0001437749-13-003698